Asset
Tafamidis
Pacira BioSciences Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (15)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01487200 | phase2 | completed | 2012-07-01 | 2012-11-01 | Pacira Pharmaceuticals, Inc | Pharmacokinetic and Pharmacodynamic Study of FX006 in Patients With Osteoarthritis of the Knee |
| NCT02468583 | phase2 | terminated | 2015-02-01 | 2016-07-01 | Pacira Pharmaceuticals, Inc | Proof of Concept Study Comparing FX006 to Kenalog®-40 in Patients With Post-Traumatic Osteoarthritis of the Knee |
| NCT02357459 | phase3 | completed | 2015-01-01 | 2016-01-01 | Pacira Pharmaceuticals, Inc | Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee |
| NCT01487161 | phase2 | completed | 2012-06-01 | 2013-04-01 | Pacira Pharmaceuticals, Inc | Study of FX006 in Patients With Osteoarthritis of the Knee |
| NCT02116972 | phase2 | completed | 2014-04-01 | 2015-11-01 | Pacira Pharmaceuticals, Inc | Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee |
FDA applications (0)
This company has no applications containing this asset.